These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 34185571)
1. Assessment of Adult Women With Ovarian Masses and Treatment of Epithelial Ovarian Cancer: ASCO Resource-Stratified Guideline. Vanderpuye VD; Clemenceau JRV; Temin S; Aziz Z; Burke WM; Cevallos NL; Chuang LT; Colgan TJ; Del Carmen MG; Fujiwara K; Kohn EC; Gonzáles Nogales JE; Konney TO; Mukhopadhyay A; Paudel BD; Tóth I; Wilailak S; Ghebre RG JCO Glob Oncol; 2021 Jun; 7():1032-1066. PubMed ID: 34185571 [TBL] [Abstract][Full Text] [Related]
2. Treatment of Patients With Early-Stage Colorectal Cancer: ASCO Resource-Stratified Guideline. Costas-Chavarri A; Nandakumar G; Temin S; Lopes G; Cervantes A; Cruz Correa M; Engineer R; Hamashima C; Ho GF; Huitzil FD; Malekzadeh Moghani M; Sharara AI; Stern MC; Teh C; Vázquez Manjarrez SE; Verjee A; Yantiss R; Shah MA J Glob Oncol; 2019 Feb; 5():1-19. PubMed ID: 30802158 [TBL] [Abstract][Full Text] [Related]
3. Systemic Treatment of Patients With Metastatic Breast Cancer: ASCO Resource-Stratified Guideline. Al Sukhun S; Temin S; Barrios CH; Antone NZ; Guerra YC; Chavez-MacGregor M; Chopra R; Danso MA; Gomez HL; Homian NM; Kandil A; Kithaka B; Koczwara B; Moy B; Nakigudde G; Petracci FE; Rugo HS; El Saghir NS; Arun BK JCO Glob Oncol; 2024 Jan; 10():e2300285. PubMed ID: 38206277 [TBL] [Abstract][Full Text] [Related]
4. Management and Care of Women With Invasive Cervical Cancer: American Society of Clinical Oncology Resource-Stratified Clinical Practice Guideline. Chuang LT; Temin S; Camacho R; Dueñas-Gonzalez A; Feldman S; Gultekin M; Gupta V; Horton S; Jacob G; Kidd EA; Lishimpi K; Nakisige C; Nam JH; Ngan HYS; Small W; Thomas G; Berek JS J Glob Oncol; 2016 Oct; 2(5):311-340. PubMed ID: 28717717 [TBL] [Abstract][Full Text] [Related]
7. Palliative Care in the Global Setting: ASCO Resource-Stratified Practice Guideline. Osman H; Shrestha S; Temin S; Ali ZV; Corvera RA; Ddungu HD; De Lima L; Del Pilar Estevez-Diz M; Ferris FD; Gafer N; Gupta HK; Horton S; Jacob G; Jia R; Lu FL; Mosoiu D; Puchalski C; Seigel C; Soyannwo O; Cleary JF J Glob Oncol; 2018 Jul; 4():1-24. PubMed ID: 30085844 [TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline. Wright AA; Bohlke K; Armstrong DK; Bookman MA; Cliby WA; Coleman RL; Dizon DS; Kash JJ; Meyer LA; Moore KN; Olawaiye AB; Oldham J; Salani R; Sparacio D; Tew WP; Vergote I; Edelson MI Gynecol Oncol; 2016 Oct; 143(1):3-15. PubMed ID: 27650684 [TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline. Wright AA; Bohlke K; Armstrong DK; Bookman MA; Cliby WA; Coleman RL; Dizon DS; Kash JJ; Meyer LA; Moore KN; Olawaiye AB; Oldham J; Salani R; Sparacio D; Tew WP; Vergote I; Edelson MI J Clin Oncol; 2016 Oct; 34(28):3460-73. PubMed ID: 27502591 [TBL] [Abstract][Full Text] [Related]
10. [Diagnostic and prognostic value of tumor markers, scores (clinical and biological) algorithms, in front of an ovarian mass suspected of an epithelial ovarian cancer: Article drafted from the French Guidelines in oncology entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY under the aegis of CNGOF and endorsed by INCa]. Bendifallah S; Body G; Daraï E; Ouldamer L Gynecol Obstet Fertil Senol; 2019 Feb; 47(2):134-154. PubMed ID: 30733191 [TBL] [Abstract][Full Text] [Related]
11. [Progress in preoperative evaluation methods regarding cytoreduction in patients with advanced ovarian cancer]. Liu J; Zhang K Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Jul; 42(7):854-859. PubMed ID: 28845013 [TBL] [Abstract][Full Text] [Related]
12. A preoperative low cancer antigen 125 level (≤25.8 mg/dl) is a useful criterion to determine the optimal timing of interval debulking surgery following neoadjuvant chemotherapy in epithelial ovarian cancer. Morimoto A; Nagao S; Kogiku A; Yamamoto K; Miwa M; Wakahashi S; Ichida K; Sudo T; Yamaguchi S; Fujiwara K Jpn J Clin Oncol; 2016 Jun; 46(6):517-21. PubMed ID: 26977055 [TBL] [Abstract][Full Text] [Related]
13. Primary Prevention of Cervical Cancer: American Society of Clinical Oncology Resource-Stratified Guideline. Arrossi S; Temin S; Garland S; Eckert LO; Bhatla N; Castellsagué X; Alkaff SE; Felder T; Hammouda D; Konno R; Lopes G; Mugisha E; Murillo R; Scarinci IC; Stanley M; Tsu V; Wheeler CM; Adewole IF; de Sanjosé S J Glob Oncol; 2017 Oct; 3(5):611-634. PubMed ID: 29094100 [TBL] [Abstract][Full Text] [Related]
15. Guideline No. 403: Initial Investigation and Management of Adnexal Masses. Salvador S; Scott S; Glanc P; Eiriksson L; Jang JH; Sebastianelli A; Dean E J Obstet Gynaecol Can; 2020 Aug; 42(8):1021-1029.e3. PubMed ID: 32736853 [TBL] [Abstract][Full Text] [Related]
16. [Surgery for advanced stage ovarian cancer: Article drafted from the French Guidelines in oncology entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY under the aegis of CNGOF and endorsed by INCa]. Ferron G; Narducci F; Pouget N; Touboul C Gynecol Obstet Fertil Senol; 2019 Feb; 47(2):197-213. PubMed ID: 30792175 [TBL] [Abstract][Full Text] [Related]
17. Risk of venous thromboembolism for ovarian cancer patients during first-line therapy after implementation of an Enhanced Recovery After Surgery (ERAS) protocol. Li S; Bercow AS; Falzone M; Kalyanaraman R; Worley MJ; Feltmate CM; Pelletier A; Elias KM Gynecol Oncol; 2021 Aug; 162(2):353-359. PubMed ID: 34092412 [TBL] [Abstract][Full Text] [Related]
18. Survival outcomes after delayed cytoreduction surgery following neoadjuvant chemotherapy in advanced epithelial ovarian cancer. Yao SE; Tripcony L; Sanday K; Robertson J; Perrin L; Chetty N; Land R; Garrett A; Obermair A; Nascimento M; Tang A; Jagasia N; Singh P; Nicklin J Int J Gynecol Cancer; 2020 Dec; 30(12):1935-1942. PubMed ID: 33122245 [TBL] [Abstract][Full Text] [Related]
19. Objective responses to first-line neoadjuvant carboplatin-paclitaxel regimens for ovarian, fallopian tube, or primary peritoneal carcinoma (ICON8): post-hoc exploratory analysis of a randomised, phase 3 trial. Morgan RD; McNeish IA; Cook AD; James EC; Lord R; Dark G; Glasspool RM; Krell J; Parkinson C; Poole CJ; Hall M; Gallardo-Rincón D; Lockley M; Essapen S; Summers J; Anand A; Zachariah A; Williams S; Jones R; Scatchard K; Walther A; Kim JW; Sundar S; Jayson GC; Ledermann JA; Clamp AR Lancet Oncol; 2021 Feb; 22(2):277-288. PubMed ID: 33357510 [TBL] [Abstract][Full Text] [Related]
20. Randomized trial of primary debulking surgery versus neoadjuvant chemotherapy for advanced epithelial ovarian cancer (SCORPION-NCT01461850). Fagotti A; Ferrandina MG; Vizzielli G; Pasciuto T; Fanfani F; Gallotta V; Margariti PA; Chiantera V; Costantini B; Gueli Alletti S; Cosentino F; Scambia G Int J Gynecol Cancer; 2020 Nov; 30(11):1657-1664. PubMed ID: 33028623 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]